CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The IMPEDE project aims to develop a new formulation of Coenzyme A precursor that can effectively treat autoimmune and inflammatory diseases. This formulation seeks to enhance the therapeutic properties of the molecule while protecting it from breakdown in the body.
Auto-immune diseases such as multiple sclerosis (MS) and rheumatoid arthritis (RA) and inflammation-associated brain diseases including Alzheimer's disease (AD) globally make up a €45B market and cost society close to €648B.
The huge number of patients with these diseases causes an enormous socioeconomic burden.
Currently, MS, AD and RA affect 120M people worldwide.
There is no cure for AD and treatments for autoimmune diseases are not fully effective and reducing the inflammatory component in t…
UNIVERSITA DEGLI STUDI DI VERONA
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
